Expression of Vascular Endothelial Growth Factor by Human Eosinophils: Upregulation by Granulocyte Macrophage Colony-stimulating Factor and Interleukin-5

American Journal of Respiratory Cell and Molecular Biology

Volumn 17, Issue 1, 1997, Pages 70-77

  Horiuchi, Tadashi ^b   Weller, Peter F ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOID; BENZOPHENANTHRIDINE DERIVATIVE; CHELERYTHRINE; DEXAMETHASONE; ENDOTHELIAL CELL GROWTH FACTOR; ENZYME INHIBITOR; GENISTEIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 5; ISOFLAVONE DERIVATIVE; LYMPHOKINE; MESSENGER RNA; PHENANTHRIDINE DERIVATIVE; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; RECOMBINANT PROTEIN; VASCULOTROPIN; VASCULOTROPIN A;

ALTERNATIVE RNA SPLICING; ARTICLE; BIOSYNTHESIS; BLOOD; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; IMMUNOLOGY; METABOLISM; POLYMERASE CHAIN REACTION; PROTEIN SYNTHESIS;

ALKALOIDS; ALTERNATIVE SPLICING; BENZOPHENANTHRIDINES; CELLS, CULTURED; DEXAMETHASONE; ENDOTHELIAL GROWTH FACTORS; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EOSINOPHILS; GENISTEIN; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-5; ISOFLAVONES; LYMPHOKINES; PHENANTHRIDINES; POLYMERASE CHAIN REACTION; PROTEIN BIOSYNTHESIS; PROTEIN KINASE C; PROTEIN-TYROSINE KINASES; RECOMBINANT PROTEINS; RNA, MESSENGER; TRANSCRIPTION, GENETIC; VARIATION (GENETICS); VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0031182836     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.17.1.2796     Document Type: Article

References (43)

1. Martin, L. B., H. Kita, K. M. Leiferman, and G. J. Gleich. 1996. Eosinophils in allergy: roles in disease, degranulation, and cytokines. Int. Arch. Allergy Immunol. 109: 207-215.
2. Weller, P. F. 1991. The immunology of eosinophils. N. Engl. J. Med. 324: 1110-1118.
3. Moqbel, R., F. Levi-Schaffer, and A. B. Kay. 1994. Cytokine generation by eosinophils. J. Allergy Clin. Immunol. 94:1183-1188.
4. Dvorak, H. F., L. F. Brown, M. Detmar, and A. M. Dvorak. 1995. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol. 146:1029-1039.
5. Thomas, K. A. 1996. Vascular endothelial growth factor, a potent and selective angiogenic agent. J. Biol. Chem. 271: 603-606.
6. Tischer, E., R. Mitchell, T. Hartman, M. Silva, D. Gospodarowicz, J. C. Fiddes, and J. A. Abraham. 1991. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem. 266:11947-11954.
7. Park, J., G.-A. Keller, and N. Ferrara. 1993. The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol. Biol. Cell 4:1317-1326.
8. Leung, D. W., G. Cachianes, W.-J. Kuang, D. V. Goeddel, and N. Ferrara. 1989. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306-1309.
9. Li, J., M. A. Perrella, J.-C. Tsai, S.-F. Yet, C.-M. Hsieh, M. Yoshizumi, C. Patterson, W. O. Endege, F. Zhou, and M.-E. Lee. 1995. Induction of vascular endothelial growth factor gene expression by interleukin-1β in rat aortic smooth muscle cells. J. Biol. Chem. 270:308-312.
10. Levy, A. P., N. S. Levy, J. Loscalzo, A. Calderone, N. Takahashi, K.-T. Yeo, G. Koren, W. S. Colucci, and M. A. Goldberg. 1995. Regulation of vascular endothelial growth factor in cardiac myocytes. Circ Res. 76:758-766.
11. Frank, S., G. Hübner, G. Breier, M. T. Longaker, D. G. Greenhalgh, and S. Werner. 1995. Regulation of vascular endothelial growth factor expression in cultured keratinocytes. J. Biol. Chem. 270:12607-12613.
12. Iijima, K., N. Yoshikawa, D. T. Connolly, and H. Nakamura. 1993. Human mesangial cells and peripheral blood mononuclear cells produce vascular permeability factor. Kidney Int. 44:959-966.
13. Roger, D. F., and T. W. Evans. 1991. Plasma exudation and oedema in asthma. Br. Med. Bull. 48:120-134.
14. Lee, T.-C., D. J. Lenihan, B. Malone, L. L. Roddy, and S. I. Wasserman. 1984. Increased biosynthesis of platelet-activating factor in activated human eosinophils. J. Biol. Chem. 259:5526-5530.
15. 4. Proc. Natl. Acad. Sci. USA 80:7626-7630.
16. Smith, H. 1992. Asthma, inflammation, eosinophils and bronchial hyperresponsiveness. Clin. Exp. Allergy 22:187-197.
17. Weller, P. F. 1992. Cytokine regulation of eosinophil function. Clin. Immunol. Immunopathol 62:S55-S59.
18. Simon, H. U., and K. Blaser. 1995. Inhibition of programmed eosinophil death: a key pathologic event for eosinophilia? Immunol. Today 16:53-55.
19. Bentley, A. M., O. Meng, D. S. Robinson, Q. Hamid, A. B. Kay, and S. R. Durham. 1993. Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics. Am. J. Respir. Cell Mol. Biol. 8:35-42.
20. Walz, T. M., B. K. Nishikawa, C. Malm, K. Briheim, and A. Wasteson. 1994. Transforming growth factor alpha expression in normal human blood eosinophils: differential regulation by granulocyte-macrophage colony-stimulating factor and interleukin-3. Leukemia 8:612-619.
21. Brach, M. A., C. Sott, M. Kiehntopf, and F. Herrmann. 1994. Expression of the transforming growth factor-alpha gene by human eosinophils is regulated by interleukin-3, interleukin-5, and granulocyte-macrophage colony-stimulating factor. Eur. J. Immunol. 24:646-650.
22. Moqbel, R., Q. Hamid, S. Ying, J. Barkans, A. Tsicopoulos, A. J. Wardlaw, and A. B. Kay. 1991. Expression of mRNA and immunoreactivity for the granulocyte/macrophage colony-stimulating factor in activated human eosinophils. J. Exp. Med. 174:749-752.
23. Alam, R., P. Forsythe, S. Stafford, and Y. Fukuda. 1994. Transforming growth factor β abrogates the effects of hematopoietins on eosinophils and induces their apoptosis. J. Exp. Med. 179:1041-1045.
24. Nakajima, H., G. J. Gleich, and H. Kita. 1996. Constitutive production of IL-4 and IL-10 and stimulated production of IL-8 by normal peripheral blood eosinophils. J. Immunol. 156:4859-4866.
25. Meagher, L. C., J. M. Cousin, J. R. Seckl, and C. Haslett. 1996. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J. Immunol. 156:4422-4428.
26. Lim, K. G., H.-C. Wan, P. T. Bozza, M. B. Resnick, D. T. W. Wong, W. W. Cruikshank, H. Kornfeld, D. M. Center, and P. F. Weiler. 1996. Human eosinophils elaborate the lymphocyte chemoattractants: IL-16 (lymphocyte chemoattractant factor) and RANTES. J. Immunol. 156:2566-2570.
27. Stern, M., L. Meagher, J. Savill, and C. Haslett. 1992. Apoptosis in human eosinophils: programmed cell death in the eosinophil leads to phagocytosis by macrophages and is modulated by IL-5. J Immunol. 148:3543-3549.
28. Siebert, P. D., and J. W. Larrick. 1993. PCR MIMICS: competitive DNA fragments for use as internal standards in quantitative PCR. BioTechniques 14:244-249.
29. Zhao, J., N. Araki, and S. K. Nishimoto. 1995. Quantitation of matrix Gla protein mRNA by competitive polymerase chain reaction using glyceraldehyde-3-phosphate dehydrogenase as an internal control. Gene 155:159-165.
30. Wong, D. T. W., P. F. Weller, S. J. Galli, A. Elovic, T. H. Rand, G. T. Gallagher, T. Chiang, M. Y. Chou, K. Matossian, J. McBride, and R. Todd. 1990. Human eosinophils express transforming growth factor-α. J. Exp. Med. 172:673-681.
31. Wong, D. T. W., A. Elovic, K. Matossian, N. Nagura, J. McBride, M. Y. Chou, J. R. Gordon, T. H. Rand, S. J. Galli, and P. F. Weller. 1991. Eosinophils from patients with blood eosinophilia express transforming growth factor β1. Blood 78:2702-2707.
32. Powell, P. P., M. Klagsburn, J. A. Abraham, and R. C. Jones. 1993. Eosinophils expressing heparin-binding EGF-like growth factor mRNA localize around lung microvessels in pulmonary hypertension. Am. J. Pathol. 143: 784-793.
33. Ohno, I., Y. Nitta, K. Yamauchi, H. Hoshi, M. Honma, K. Woolley, P. O'Byrne, J. Dolovich, M. Jordana, G. Taura, Y. Tanno, and K. Shirato. 1995. Eosinophils as a potential source of platelet-derived growth factor B-chain (PDGF-B) in nasal polyposis and bronchial asthma. Am. J. Respir. Cell Mol. Biol. 13:639-647.
34. Clutterbuck, E. J., E. M. Hirst, and C. J. Sanderson. 1989. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6, and GM-CSF. Blood 73:1504-1512.
35. Sonoda, Y., N. Arai, and M. Ogawa. 1989. Humoral regulation of eosinophilopoiesis in vitro: analysis of the targets of interleukin-3. granulocyte/macrophage colony-stimulating factor (GM-CSF). and interleukin-5. Leukemia 3:14-18.
36. Beil, W. J., P. F. Weller, D. M. Tzizik, S. J. Galli, and A. M. Dvorak. 1993. Ultrastructural immunogold localization of tumor necrosis factor-α to the matrix compartment of eosinophil secondary granules in patients with idiopathic hypereosinophilic syndrome. J. Histochem. Cytochem. 41:1611-1615.
37. Levi-Schaffer, F., P. Lacy, N. J. Severs, T. M. Newman, J. North, B. Gompers, A. B. Kay, and R. Moqbel. 1995. Association of granulocyte-macrophage colony-stimulating factor with the crystalloid granules of human eosinophils. Blood 85:2579-2586.
38. Moqbel, R., S. Ying, J. Barkans, T. M. Newman, P. Kimmitt, M. Wakelin, L. Taborda-Barata, Q. Meng, C. J. Corrigan, S. R. Durham, and A. B. Kay. 1995. Identification of messenger RNA for IL-4 in human eosinophils with granule localization and release of the translated product. J. Immunol. 155: 4939-4947.
39. Houck, K. A., D. W. Leung, A. M. Rowland, J. Winer, and N. Ferrara. 1992. Dual regulation of vascular endothelial growth factor bioactivity by genetic and proteolytic mechanism. J. Biol. Chem. 267:26031-26037.
40. Schleimer, R. P., and B. S. Bochner. 1994. The effects of glucocorticoids on human eosinophils. J. Allergv Clin. Immunol. 94:1202-1213.
41. Wallen, N., H. Kita, D. Weiler, and G. J. Gleich. 1991. Glucocorticoids inhibit cytokine-mediated eosinophil survival. J. Immunol. 147:3490-3495.
42. Taniguchi, T. 1995. Cytokine signaling through nonreceptor protein tyrosine kinases. Science 268:251-255.
43. Bates, M. E., P. J. Bertics, and W. W. Busse. 1996. IL-5 activates a 45-kilodalton mitogen-activated protein (MAP) kinase and Jak-2 tyrosine kinase in human eosinophils. J. Immunol. 156:711-718.